.INVESTIGATION EMPHASIZE.06 August 2024.
A large randomized measured test along with cisgender women highlights the challenges of faithfulness to a daily oral preexposure treatment regiment and also shows that twice-yearly injection of lenacapavir can easily sustain efficient HIV deterrence levels over 6 months.